CME Cost Of Revenue vs Total Revenue Analysis

CME Stock

USD 213.14 0.41 0.19%

CME financial indicator trend analysis is way more than just evaluating CME Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CME Group is a good investment. Please check the relationship between CME Cost Of Revenue and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CME Group Cost Of Revenue account and Total Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between CME's Cost Of Revenue and Total Revenue is 0.96. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of CME Group, assuming nothing else is changed. The correlation between historical values of CME's Cost Of Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of CME Group are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Cost Of Revenue i.e., CME's Cost Of Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on CME Group income statement and represents the costs associated with goods and services CME provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Revenue

Total revenue comprises all receipts CME Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from CME's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At present, CME's Enterprise Value is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	3.9B	4.3B	4.5B	2.5B
Total Revenue	4.7B	5.0B	5.6B	3.0B

Gross Profit Total Revenue

CME fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.58	0.99	0.99	0.63	-0.06	0.15	0.08	0.58	0.58	0.8	0.55	-0.24	-0.24	0.6	0.02	0.54	0.63	0.55	0.34	-0.29	0.63	1.0	0.35	0.99	0.52
Short Long Term Debt Total	0.58		0.49	0.49	0.9	0.26	0.51	0.71	0.87	0.79	0.56	0.89	0.02	0.05	0.95	0.03	0.44	0.7	0.81	0.76	-0.11	0.89	0.52	0.32	0.49	0.76
Other Current Liab	0.99	0.49		1.0	0.52	-0.12	0.05	-0.01	0.48	0.52	0.75	0.44	-0.28	-0.28	0.5	-0.03	0.51	0.55	0.43	0.21	-0.28	0.52	1.0	0.29	1.0	0.44
Total Current Liabilities	0.99	0.49	1.0		0.52	-0.12	0.04	-0.01	0.49	0.53	0.75	0.44	-0.3	-0.27	0.51	-0.03	0.5	0.55	0.43	0.21	-0.27	0.52	1.0	0.29	1.0	0.44
Total Stockholder Equity	0.63	0.9	0.52	0.52		0.26	0.64	0.5	0.94	0.61	0.6	0.99	0.13	0.08	0.9	0.22	0.33	0.68	0.97	0.89	0.0	1.0	0.56	0.29	0.52	0.78
Other Liab	-0.06	0.26	-0.12	-0.12	0.26		0.33	-0.04	0.19	-0.04	0.35	0.3	0.23	0.88	0.12	0.28	-0.01	0.13	0.32	0.39	0.04	0.26	-0.1	0.12	-0.12	0.15
Property Plant And Equipment Net	0.15	0.51	0.05	0.04	0.64	0.33		0.34	0.63	0.18	0.3	0.67	0.43	0.33	0.47	0.65	0.27	0.22	0.69	0.72	-0.19	0.63	0.08	0.59	0.05	0.24
Net Debt	0.08	0.71	-0.01	-0.01	0.5	-0.04	0.34		0.58	0.62	-0.09	0.52	0.19	-0.07	0.72	0.0	0.2	0.28	0.4	0.47	0.07	0.47	0.02	0.12	-0.01	0.31
Retained Earnings	0.58	0.87	0.48	0.49	0.94	0.19	0.63	0.58		0.61	0.47	0.91	0.18	0.1	0.86	0.29	0.26	0.52	0.86	0.75	0.07	0.9	0.52	0.25	0.49	0.62
Accounts Payable	0.58	0.79	0.52	0.53	0.61	-0.04	0.18	0.62	0.61		0.41	0.57	-0.49	-0.21	0.8	-0.05	0.45	0.48	0.46	0.4	-0.17	0.6	0.55	0.23	0.53	0.5
Cash	0.8	0.56	0.75	0.75	0.6	0.35	0.3	-0.09	0.47	0.41		0.56	-0.2	0.06	0.51	0.05	0.69	0.77	0.62	0.45	-0.53	0.62	0.77	0.6	0.75	0.58
Non Current Assets Total	0.55	0.89	0.44	0.44	0.99	0.3	0.67	0.52	0.91	0.57	0.56		0.17	0.12	0.89	0.23	0.3	0.68	0.98	0.95	0.03	0.99	0.48	0.28	0.44	0.78
Non Currrent Assets Other	-0.24	0.02	-0.28	-0.3	0.13	0.23	0.43	0.19	0.18	-0.49	-0.2	0.17		0.35	-0.06	0.4	-0.17	-0.15	0.19	0.26	0.15	0.1	-0.28	0.07	-0.3	-0.12
Other Assets	-0.24	0.05	-0.28	-0.27	0.08	0.88	0.33	-0.07	0.1	-0.21	0.06	0.12	0.35		-0.11	0.31	-0.29	-0.15	0.12	0.22	0.23	0.06	-0.26	-0.05	-0.27	-0.06
Long Term Debt	0.6	0.95	0.5	0.51	0.9	0.12	0.47	0.72	0.86	0.8	0.51	0.89	-0.06	-0.11		0.06	0.49	0.7	0.82	0.77	-0.13	0.89	0.54	0.34	0.51	0.72
Cash And Short Term Investments	0.02	0.03	-0.03	-0.03	0.22	0.28	0.65	0.0	0.29	-0.05	0.05	0.23	0.4	0.31	0.06		0.05	-0.36	0.26	0.25	-0.06	0.2	-0.01	0.35	-0.02	-0.38
Net Receivables	0.54	0.44	0.51	0.5	0.33	-0.01	0.27	0.2	0.26	0.45	0.69	0.3	-0.17	-0.29	0.49	0.05		0.61	0.33	0.21	-0.91	0.34	0.51	0.88	0.5	0.29
Common Stock Total Equity	0.63	0.7	0.55	0.55	0.68	0.13	0.22	0.28	0.52	0.48	0.77	0.68	-0.15	-0.15	0.7	-0.36	0.61		0.71	0.62	-0.36	0.71	0.58	0.42	0.55	0.87
Common Stock Shares Outstanding	0.55	0.81	0.43	0.43	0.97	0.32	0.69	0.4	0.86	0.46	0.62	0.98	0.19	0.12	0.82	0.26	0.33	0.71		0.95	-0.03	0.98	0.48	0.34	0.44	0.77
Non Current Liabilities Total	0.34	0.76	0.21	0.21	0.89	0.39	0.72	0.47	0.75	0.4	0.45	0.95	0.26	0.22	0.77	0.25	0.21	0.62	0.95		0.07	0.91	0.26	0.27	0.22	0.72
Other Current Assets	-0.29	-0.11	-0.28	-0.27	0.0	0.04	-0.19	0.07	0.07	-0.17	-0.53	0.03	0.15	0.23	-0.13	-0.06	-0.91	-0.36	-0.03	0.07		-0.02	-0.28	-0.89	-0.28	-0.03
Other Stockholder Equity	0.63	0.89	0.52	0.52	1.0	0.26	0.63	0.47	0.9	0.6	0.62	0.99	0.1	0.06	0.89	0.2	0.34	0.71	0.98	0.91	-0.02		0.56	0.3	0.53	0.81
Total Liab	1.0	0.52	1.0	1.0	0.56	-0.1	0.08	0.02	0.52	0.55	0.77	0.48	-0.28	-0.26	0.54	-0.01	0.51	0.58	0.48	0.26	-0.28	0.56		0.31	1.0	0.47
Property Plant And Equipment Gross	0.35	0.32	0.29	0.29	0.29	0.12	0.59	0.12	0.25	0.23	0.6	0.28	0.07	-0.05	0.34	0.35	0.88	0.42	0.34	0.27	-0.89	0.3	0.31		0.29	0.1
Total Current Assets	0.99	0.49	1.0	1.0	0.52	-0.12	0.05	-0.01	0.49	0.53	0.75	0.44	-0.3	-0.27	0.51	-0.02	0.5	0.55	0.44	0.22	-0.28	0.53	1.0	0.29		0.44
Common Stock	0.52	0.76	0.44	0.44	0.78	0.15	0.24	0.31	0.62	0.5	0.58	0.78	-0.12	-0.06	0.72	-0.38	0.29	0.87	0.77	0.72	-0.03	0.81	0.47	0.1	0.44

Click cells to compare fundamentals

CME Account Relationship Matchups

CME fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	75.2B	124.7B	196.8B	174.2B	129.8B	136.3B
Short Long Term Debt Total	3.7B	3.4B	3.4B	3.4B	3.9B	2.4B
Other Current Liab	38.5B	88.1B	159.6B	132.2B	93.3B	98.0B
Total Current Liabilities	38.5B	88.2B	160.4B	137.7B	93.4B	98.1B
Total Stockholder Equity	26.1B	26.3B	27.4B	26.9B	26.7B	17.6B
Other Liab	6.2B	6.7B	6.3B	5.7B	6.6B	6.2B
Property Plant And Equipment Net	544M	579.2M	505.3M	455.5M	681.5M	483.4M
Net Debt	2.2B	1.8B	610.2M	718.3M	966.7M	843.5M
Retained Earnings	5.0B	5.0B	5.2B	4.7B	4.5B	3.0B
Accounts Payable	61.9M	69.3M	48.8M	121.4M	90.6M	51.7M
Cash	1.6B	1.6B	2.8B	2.7B	2.9B	3.1B
Non Current Assets Total	35.6B	35.4B	35.0B	35.1B	34.8B	24.0B
Non Currrent Assets Other	2.1B	2.0B	3.3B	(3.1B)	514.1M	1.0B
Other Assets	545.9M	7.3B	3.3B	574M	134.4M	127.7M
Long Term Debt	3.7B	3.4B	2.7B	3.4B	3.4B	2.5B
Cash And Short Term Investments	1.6B	1.7B	2.9B	2.8B	3.0B	2.7B
Net Receivables	491.8M	461.3M	434.5M	483.2M	1.3B	1.3B
Common Stock Shares Outstanding	358.2M	358.5M	358.9M	359.2M	359.5M	311.9M
Liabilities And Stockholders Equity	75.2B	124.7B	196.8B	174.2B	129.8B	136.3B
Non Current Liabilities Total	10.5B	10.1B	9.0B	9.6B	9.6B	7.4B
Other Current Assets	360.1M	302M	423M	524.9M	(4.3B)	(4.1B)
Other Stockholder Equity	21.1B	21.2B	22.2B	22.3B	22.3B	14.5B
Total Liab	49.1B	98.3B	169.4B	147.3B	103.1B	108.3B
Property Plant And Equipment Gross	544M	579.2M	505.3M	455.5M	1.3B	1.4B
Total Current Assets	39.6B	89.3B	161.8B	139.1B	94.9B	99.6B
Accumulated Other Comprehensive Income	3.4M	134.9M	53.5M	(133.3M)	(55.6M)	(52.8M)
Property Plant Equipment	544M	579.2M	505.3M	837.6M	963.2M	490.1M
Short Term Investments	83.2M	100.9M	115M	96M	111.7M	106.1M
Inventory	37.1B	86.8B	158.0B	135.3B	155.5B	163.3B
Short Term Debt	49.7M	52.2M	749.4M	16M	55.1M	52.3M
Intangible Assets	22.3B	22.0B	20.7B	20.4B	20.2B	18.4B
Good Will	10.7B	10.8B	10.5B	10.5B	10.5B	8.9B
Retained Earnings Total Equity	4.9B	5.0B	5.0B	5.2B	5.9B	3.7B
Deferred Long Term Liab	5.7B	5.6B	5.6B	5.4B	6.2B	4.7B
Net Tangible Assets	(6.9B)	(6.5B)	(3.8B)	(4.0B)	(4.7B)	(4.9B)
Long Term Debt Total	3.8B	3.7B	3.4B	2.7B	3.1B	2.9B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
GOOG	Alphabet Inc Class C
C	Citigroup

When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:

How To Invest In CME

Details

Is CME Stock a good investment?

Details

What is CME's Net Worth?

Details

Largest Financial Data & Stock Exchanges Companies

View

Largest Financial Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years

Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.03)

Dividend Share

4.45

Earnings Share

8.78

Revenue Per Share

15.638

Quarterly Revenue Growth

0.032

The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CME Cost Of Revenue vs Total Revenue Analysis

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Total Revenue

CME fundamental ratios Correlations

CME Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CME fundamental ratios Accounts

Also Currently Popular

Complementary Tools for CME Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Other Current Liab
Total Current Assets	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Current Liabilities

Other Current Assets	- 0.91	Net Receivables
Property Plant And Equipment Gross	- 0.89	Other Current Assets
Other Current Assets	- 0.53	Cash
Non Currrent Assets Other	- 0.49	Accounts Payable
Common Stock	- 0.38	Cash And Short Term Investments
Other Current Assets	- 0.36	Common Stock Total Equity